← Leaderboards
Huimin Zhao
University Of Illinois Urbana-Champaign
$5,694,306
Attributed
$9,208,111
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $770.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,208,111 · 7
By mechanism
R01$5,270,708 · 1
P01$3,466,112 · 2
R21$411,432 · 1
P41$59,859 · 3
Top collaborators
- Douglas Alan Mitchell7 shared
- Willem A Van Der Donk7 shared
Most similar at University Of Illinois Urbana-Champaign
Same institution · by research overlap
- Willem A Van Der Donk$17,237,843
- William W. Metcalf$9,518,308
- Silvia N Moreno$16,839,808
- Neil L Kelleher$32,542,329
- Pieter C Dorrestein$10,925,542
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsEscherichia ColiSourcePathway InteractionsProductionBaseDesignGenesEngineeringEnzymesStructureCloningBiologicalCombinatorialMetabolicSynthetic BiologyGene ExpressionScaffoldMalariaAnabolismProgramsPharmaceutical PreparationsDirected EvolutionAntimalarials
Grant awards (23)
A Next-Generation Scalable Platform to Discover Antimicrobials of Ribosomal Origin$743,463
R01 · FY2025 · AI · contact PI
A Next-Generation Scalable Platform to Discover Antimicrobials of Ribosomal Origin$743,463
R01 · FY2024 · AI · contact PI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$770,174
R01 · FY2023 · AI · contact PI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$770,174
R01 · FY2022 · AI · contact PI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$748,142
R01 · FY2021 · AI · contact PI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$749,232
R01 · FY2020 · AI · contact PI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$746,060
R01 · FY2019 · AI · contact PI
Biosynthesis via Synthetic Biology$314,050
P01 · FY2016 · GM · contact PI
Biosynthesis via Synthetic Biology$314,050
P01 · FY2015 · GM · contact PI
Biosynthesis via Synthetic Biology$314,050
P01 · FY2014 · GM · contact PI
Biosynthesis via Synthetic Biology$303,056
P01 · FY2013 · GM · contact PI
Biosynthesis via Synthetic Biology$314,050
P01 · FY2012 · GM · contact PI
PROTEIN AND METABOLIC ENGINEERING FOR BIOSYNTHESIS OF PHOSPHONIC ACID ANTIBIOTICS$373,399
P01 · FY2011 · GM · contact PI
PROTEIN AND METABOLIC ENGINEERING FOR BIOSYNTHESIS OF PHOSPHONIC ACID ANTIBIOTICS$379,640
P01 · FY2010 · GM · contact PI
PROTEIN AND METABOLIC ENGINEERING FOR BIOSYNTHESIS OF PHOSPHONIC ACID ANTIBIOTICS$374,291
P01 · FY2009 · GM · contact PI
Directed Evolution of Homing Endonucleases for Human Gene Therapy$224,982
R21 · FY2009 · HL · contact PI
PROTEIN AND METABOLIC ENGINEERING FOR BIOSYNTHESIS OF PHOSPHONIC ACID ANTIBIOTICS$375,455
P01 · FY2008 · GM · contact PI
Directed Evolution of Homing Endonucleases for Human Gene Therapy$186,450
R21 · FY2008 · HL · contact PI
PROTEIN AND METABOLIC ENGINEERING FOR BIOSYNTHESIS OF PHOSPHONIC ACID ANTIBIOTICS$404,071
P01 · FY2007 · GM · contact PI
DIRECTED EVOLUTION OF A THERMOSTABLE PHOSPHITE DEHYDROGENASE$31,739
P41 · FY2006 · RR · contact PI
STUDY OF BINDING CONSTANTS FOR WILD-TYPE &MUTANT PHOSPHITE DEHYDROGENASE$5,789
P41 · FY2005 · RR
DIRECTED EVOLUTION OF A THERMOSTABLE PHOSPHITE DEHYDROGENASE$3,047
P41 · FY2005 · RR
STUDY OF BINDING CONSTANTS FOR WILD-TYPE &MUTANT PHOSPHITE DEHYDROGENASE$19,284
P41 · FY2004 · RR